PCOS患者控制性超排卵方案的选择及比较
被引量:2
摘要
PCOS是一种异质性疾病,具有多种表型,对促排卵药物反应异常,目前超排卵方案和超排卵药物多种多样,选择合适的控制性超排卵方案是PCOS患者获得ART成功的关键。
出处
《生殖与避孕》
CAS
CSCD
北大核心
2007年第10期672-678,共7页
Reproduction and Contraception
参考文献32
-
1刘英,王树玉,张军,马延敏,任国庆,余兰.两种促卵泡生长激素在辅助生殖治疗效果的比较[J].生殖医学杂志,2004,13(3):172-174. 被引量:3
-
2Bayram N,van Wely M,Patrono C,et al.Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Syst Rev,2001,1(2):CD002121.
-
3Wood C,Downing B,Trounson A,et al.Clinical implations of develoments in in vitro fertilisation.Br Med J (Clin Res Ed),1984,289(6 450):978-80.
-
4Hsieh Y,Tsai H,Chang C,et al.Comparison of a single half-dose long-acting form of gonadotropin-releasing hormone analog(GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program.Fertil Steril,2000,73(4):817-20.
-
5Franks S,Adamas J,Mason H,et al.Ovulatory disorders in women with polycystic ovary syndrome.Clin Obestet Gynecol,1985,12(3):605-32.
-
6Biljan MM,Mahutte NG,Tulandi T,et al.Prospective randomized double blind trail of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive endovgans.Fertil Steril,1999,71 (4):633-8.
-
7木元正和(张维嘉摘).克罗米酚的增量、长期用药法[J].国外医学:计划生育分册,2001,20(2):119-119.
-
8Porter RN,Smith W,Craft IL,et al.Induction for in vitro fertilization using buserlin and gonadotropins.Lancet,1984,2(8 414):1 284-5.
-
9Nugent D,Vandekerchhove P,Weber SM,et al.Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Sys Rev,2000,3(4):CD000410.
-
10Bahceci M,Ulug U,Pockj BA,et al.Use ofa GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovarydisease:a randomized,prospective,pilot study.J Reprod Med,2005,50(2):84-90.
二级参考文献33
-
1刘锦霞,冷雯.多囊卵巢综合征患者外周血生长激素水平测定[J].生殖医学杂志,1994,3(3):150-152. 被引量:3
-
2Steer CV, Mills CL, Tan Sl, et al. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme[J]. Hum Reprod, 1992, 7(1): 117-119.
-
3Fulghesu AM, Apa R, Belosi C, et al. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment[J]. Horm Res, 2001, 55(5): 224-228.
-
4Battaglia C, Salvatori M, Regnani G, et al. Allergic reaction to a highly purified urinary follicle stimulating hormone preparation in controlled ovarian hyperstimulation for in vitro fertilization[J]. Gynecol Endocrinol, 2000,14(3):158-161.
-
5Lenton E, Soltan A, Hewitt J, et al. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)[J]. Hum Reprod, 2000, 15(5): 1021-1027.
-
6Kably A, Castelazo E, Barroso G. Comparative analysis of multifollicular development with the application of recombinant FSH vs urinary FSH in the results of in vitro fertilization[J]. Gynecol Obstet Mex, 2001, 69(2): 304-309.
-
7Hugues JN, Bstandig B, Bry-Gauillard H, et al. Comparison of the effectiveness of recombinant and urinary FSH preparations in the achievement of follicular selection in chronic anovulation[J]. Reprod Biomed Online,2001, 3(3): 195-198.
-
8Robertson WR. Gonadotrophin isoform patterns in different pharmaceutical preparations[A]. In: Kahn JA (ed). Gonadotropin isoforms: facts and future. Serono fertility series. Vol 2. Copenhagen: Ciconia Foundation, 1997.53-60.
-
9Yong PY, Brett S, Baird DT, et al. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment[J]
-
10Lathi RB, Milki AA. Recombinant gonadotropins[J]. Curr Womens Health Rep, 2001 , 1(2):157-163.
共引文献137
-
1钟海英,杨玲玲,肖孝凤.中药联合耳穴治疗脾肾阳虚型多囊卵巢综合征30例临床观察[J].中国民族民间医药,2019,28(13):98-100. 被引量:7
-
2陈子江,哈灵侠.多囊卵巢综合征治疗进展[J].中华糖尿病杂志,2009,1(6). 被引量:1
-
3李雪梅,朱文杰,陈秀敏,张黎.生长激素在体外受精周期中的应用初探[J].实用医学杂志,2004,20(8):883-884. 被引量:3
-
4赵立芬,张延辉,张静,许薇,翁宁.终止早期妊娠方法的现状[J].中国计划生育学杂志,2004,12(10):636-638. 被引量:4
-
5姚雪芹.生长激素与多囊卵巢综合征中内分泌激素关系的探讨[J].贵州医药,2004,28(9):807-809.
-
6陈静,徐望明,杨菁.腹腔镜下卵巢打孔术对耐药多囊卵巢综合征妇女生长激素轴的影响[J].第四军医大学学报,2005,26(4):352-354. 被引量:7
-
7孙晓峰,尤照玲,孙启春.生长激素与多囊卵巢综合征关系的研究进展[J].湖南中医杂志,2005,21(2):81-83. 被引量:4
-
8鹿群,马金龙,高选,赵跃然,陈子江.钙离子载体A23187联合嘌呤霉素对人体外成熟卵母细胞孤雌激活作用的研究[J].山东大学学报(医学版),2005,43(8):685-689. 被引量:2
-
9张丽珠.我国大陆“试管婴儿”研究进展[J].生物学通报,1996,31(5):1-4. 被引量:17
-
10鹿群,陈子江,高选,李媛,颜军昊,马水英,李梅.人工激活胚胎的性染色体分析和IGF-Ⅱ表达研究[J].中华医学遗传学杂志,2005,22(5):524-527. 被引量:3
同被引文献19
-
1张烁,杨晓丽,阎梦民,邓洋.基因重组卵泡刺激素促排卵效果的观察[J].山西医药杂志,2005,34(12):1033-1034. 被引量:8
-
2陈新娜,卢光秀,严敬明,陈子江,肖红梅,陈贵安.重组FSH-β注射液在辅助生殖中的应用[J].实用妇产科杂志,2006,22(5):287-289. 被引量:2
-
3中华医学会(主编).临床诊疗指南-辅助生殖与精予库分册.北京:人民卫生出版社,2009:81.
-
4全松,陈雷宁(主译).体外受精与辅助生殖.北京:人民卫生出版社,2009:156.
-
5Christin-Maitre S, Hugues JN, Recombinant FSH Study Group. A comparative randomized multicentric study com paring the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod, 2003,18(8):1626-31.
-
6Sibug RM, Datson N, Tijssen AMI, et al. Effects of urinary and recombinant gonadotrophins on gene expression profiles during the murine peri-implantation period. Hum Reprod, 2007, 22(1):75-82.
-
7Yovel I, Yajon Y, Amit A, et al. High progesterone levels adversely effect embryo quality and pregnancy rates in vitro fertilization and oocyte donation programs. Fertil Steril, 1995, 64(1):128.
-
8Teisser M, Chable H, Paulhac S, et al. Recombinant human follicle stimulating hormone versus human menopausal go- nadotrophin induction: effects in mature follicle endocrinology. Hum Reprod, 1999, 14(9):2236-41.
-
9Marrs RP, Meldrum DR, Muasher S J, et al. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online, 2004, 8(2): 175-82.
-
10关冰.多囊卵巢综合症临床特点分析及诊治进展[J].中国医药指南,2007,5(7):102-105. 被引量:24
引证文献2
-
1张莉莉,赵丽辉,贾学玲,张学红.多囊卵巢综合征患者IVF治疗中超促排卵方案的对比研究[J].生殖与避孕,2011,31(1):18-24. 被引量:3
-
2邢琪,肖雪晴,滕雪峰,蔡亚男.标准长方案对汉族、维吾尔族PCOS患者IVF-ET结局的影响[J].新疆医学,2014,44(11):11-13.
二级引证文献3
-
1毛增辉,汤乐,唐君.微刺激促排卵方案在多囊卵巢综合征患者体外受精-胚胎移植中的应用[J].现代医药卫生,2015,31(24):3782-3783. 被引量:3
-
2任玉霞,高明霞,赵丽辉.多囊卵巢综合征患者取卵术后能量支持对预防卵巢过度刺激综合征的临床研究[J].卫生职业教育,2016,34(15):147-149. 被引量:1
-
3胡芸.不同促排卵药物治疗多囊卵巢综合征对患者子宫及卵巢血流的影响[J].中国生育健康杂志,2018,29(6):567-569. 被引量:11
-
1齐新宇,庞艳莉,乔杰.多囊卵巢综合征代谢异常的研究进展[J].中华医学杂志,2016,96(9):747-749. 被引量:25
-
2邹芳.多囊卵巢综合征诊治体会[J].现代实用医学,2003,15(3):170-171. 被引量:4
-
3俞瑾.中西医结合治疗多囊卵巢综合征50年[J].中国中西医结合杂志,2009,29(7):585-586. 被引量:4
-
4李晓丹,孔芬英,王艳芬,韩转叶,王岩英.二甲双胍治疗多囊卵巢综合征36例临床观察[J].河北医药,2009,31(11):1352-1353. 被引量:1
-
5滕悦,李英.导致胎儿危险的药物反应[J].吉林医学情报,1991(5):17-18.
-
6谭利,王秀兰.药物保守治疗异位妊娠疗效观察[J].中国实用医药,2010,5(8):143-144.
-
7李彩萍,周海玲,马麟,段启.米非司酮配伍米索前列醇终止10-16周妊娠的临床研究[J].临床医学工程,2008,15(11):24-25.
-
8李怡梅,丘映.控制性超排卵治疗中卵巢高反应影响因素分析[J].生殖与避孕,2010,30(8):533-538. 被引量:5
-
9高姗姗,李媛.多囊卵巢综合征与代谢综合征的关系[J].中华妇产科杂志,2008,43(2):152-153. 被引量:3
-
10徐亚娟.米索前列醇与催产素防治疤痕子宫产后出血观察[J].浙江预防医学,2004,16(6):55-55.